385 related articles for article (PubMed ID: 10499587)
1. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14.
Ames RS; Sarau HM; Chambers JK; Willette RN; Aiyar NV; Romanic AM; Louden CS; Foley JJ; Sauermelch CF; Coatney RW; Ao Z; Disa J; Holmes SD; Stadel JM; Martin JD; Liu WS; Glover GI; Wilson S; McNulty DE; Ellis CE; Elshourbagy NA; Shabon U; Trill JJ; Hay DW; Ohlstein EH; Bergsma DJ; Douglas SA
Nature; 1999 Sep; 401(6750):282-6. PubMed ID: 10499587
[TBL] [Abstract][Full Text] [Related]
2. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14.
Liu Q; Pong SS; Zeng Z; Zhang Q; Howard AD; Williams DL; Davidoff M; Wang R; Austin CP; McDonald TP; Bai C; George SR; Evans JF; Caskey CT
Biochem Biophys Res Commun; 1999 Dec; 266(1):174-8. PubMed ID: 10581185
[TBL] [Abstract][Full Text] [Related]
3. A new ligand for the urotensin II receptor.
Camarda V; Guerrini R; Kostenis E; Rizzi A; Calò G; Hattenberger A; Zucchini M; Salvadori S; Regoli D
Br J Pharmacol; 2002 Oct; 137(3):311-4. PubMed ID: 12237249
[TBL] [Abstract][Full Text] [Related]
4. Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents.
Camarda V; Rizzi A; Calò G; Gendron G; Perron SI; Kostenis E; Zamboni P; Mascoli F; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):141-9. PubMed ID: 11819032
[TBL] [Abstract][Full Text] [Related]
5. Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14).
Mori M; Sugo T; Abe M; Shimomura Y; Kurihara M; Kitada C; Kikuchi K; Shintani Y; Kurokawa T; Onda H; Nishimura O; Fujino M
Biochem Biophys Res Commun; 1999 Nov; 265(1):123-9. PubMed ID: 10548501
[TBL] [Abstract][Full Text] [Related]
6. [A vasoactive peptide: urotensin II].
Liu GQ; Zeng ZP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):525-8. PubMed ID: 16178453
[TBL] [Abstract][Full Text] [Related]
7. Functional and binding characterizations of urotensin II-related peptides in human and rat urotensin II-receptor assay.
Brkovic A; Hattenberger A; Kostenis E; Klabunde T; Flohr S; Kurz M; Bourgault S; Fournier A
J Pharmacol Exp Ther; 2003 Sep; 306(3):1200-9. PubMed ID: 12807997
[TBL] [Abstract][Full Text] [Related]
8. Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey.
Elshourbagy NA; Douglas SA; Shabon U; Harrison S; Duddy G; Sechler JL; Ao Z; Maleeff BE; Naselsky D; Disa J; Aiyar NV
Br J Pharmacol; 2002 May; 136(1):9-22. PubMed ID: 11976263
[TBL] [Abstract][Full Text] [Related]
9. Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain.
Boucard AA; Sauvé SS; Guillemette G; Escher E; Leduc R
Biochem J; 2003 Mar; 370(Pt 3):829-38. PubMed ID: 12495432
[TBL] [Abstract][Full Text] [Related]
10. The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems.
Behm DJ; Stankus G; Doe CP; Willette RN; Sarau HM; Foley JJ; Schmidt DB; Nuthulaganti P; Fornwald JA; Ames RS; Lambert DG; Calo' G; Camarda V; Aiyar NV; Douglas SA
Br J Pharmacol; 2006 May; 148(2):173-90. PubMed ID: 16547525
[TBL] [Abstract][Full Text] [Related]
11. Recent structure-activity studies of the peptide hormone urotensin-II, a potent vasoconstrictor.
Grieco P; Rovero P; Novellino E
Curr Med Chem; 2004 Apr; 11(8):969-79. PubMed ID: 15078159
[TBL] [Abstract][Full Text] [Related]
12. Urotensin II: the old kid in town.
Onan D; Hannan RD; Thomas WG
Trends Endocrinol Metab; 2004; 15(4):175-82. PubMed ID: 15109617
[TBL] [Abstract][Full Text] [Related]
13. Role of urotensin II in peripheral tissue as an autocrine/paracrine growth factor.
Yoshimoto T; Matsushita M; Hirata Y
Peptides; 2004 Oct; 25(10):1775-81. PubMed ID: 15476945
[TBL] [Abstract][Full Text] [Related]
14. Another ligand fishing for G protein-coupled receptor 14. Discovery of urotensin II-related peptide in the rat brain.
Sugo T; Mori M
Peptides; 2008 May; 29(5):809-12. PubMed ID: 17628210
[TBL] [Abstract][Full Text] [Related]
15. Alteration of vascular urotensin II receptor in mice with apolipoprotein E gene knockout.
Wang ZJ; Shi LB; Xiong ZW; Zhang LF; Meng L; Bu DF; Tang CS; Ding WH
Peptides; 2006 Apr; 27(4):858-63. PubMed ID: 16325305
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and characterization of two novel retinoic acid-inducible orphan G-protein-coupled receptors (GPRC5B and GPRC5C).
Robbins MJ; Michalovich D; Hill J; Calver AR; Medhurst AD; Gloger I; Sims M; Middlemiss DN; Pangalos MN
Genomics; 2000 Jul; 67(1):8-18. PubMed ID: 10945465
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist.
Chatenet D; Dubessy C; Boularan C; Scalbert E; Pfeiffer B; Renard P; Lihrmann I; Pacaud P; Tonon MC; Vaudry H; Leprince J
J Med Chem; 2006 Nov; 49(24):7234-8. PubMed ID: 17125276
[TBL] [Abstract][Full Text] [Related]
18. Cloning, pharmacology, and tissue distribution of G-protein-coupled receptor GPR105 (KIAA0001) rodent orthologs.
Freeman K; Tsui P; Moore D; Emson PC; Vawter L; Naheed S; Lane P; Bawagan H; Herrity N; Murphy K; Sarau HM; Ames RS; Wilson S; Livi GP; Chambers JK
Genomics; 2001 Dec; 78(3):124-8. PubMed ID: 11735218
[TBL] [Abstract][Full Text] [Related]
19. Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey.
Douglas SA; Sulpizio AC; Piercy V; Sarau HM; Ames RS; Aiyar NV; Ohlstein EH; Willette RN
Br J Pharmacol; 2000 Dec; 131(7):1262-74. PubMed ID: 11090097
[TBL] [Abstract][Full Text] [Related]
20. Urotensin-II receptor peptide agonists.
Carotenuto A; Grieco P; Novellino E; Rovero P
Med Res Rev; 2004 Sep; 24(5):577-88. PubMed ID: 15224381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
